Coronary/Structural Heart

Edwards’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes

PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the Edwards CENTERA valve. These new […]

Head-to-Head Study Validates Consistent Performance of Microcatheter FFR

PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]

Teleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump and the Product Portfolio from the Recently Acquired Vascular Solutions, Inc. at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR)

WAYNE, Pa.–(BUSINESS WIRE)–May 15, 2017– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR […]

Edwards Lifesciences (EW)’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes

PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the Edwards CENTERA valve. These new […]

Acist Medical Systems, Inc. Release: Head-to-Head Study Validates Consistent Performance Of Microcatheter FFR

PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]

Elixir Medical Announces Outstanding 5-Year Clinical Data For CE Mark-Approved Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, today announced excellent 5-year clinical data from the DESolve Nx international pivotal clinical trial for the CE Mark-approved, fully bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System. Stefan Verheye, MD, PhD, ZNA Middleheim Hospital, […]

What is the Significance of Lipid-rich Plaque and Should it Influence Targets for PCI?

By Ken Dropiewski Lipid-rich plaque in non-culprit lesions has long been associated with subsequent cardiac events. Unlike culprit lesions, known to be the cause of AMI, non-culprit lesions including those with a core of lipid-rich plaque are often left untreated during an intervention. The fact that these lesions may lead […]

Shockwave Medical Snags CE Mark for Coronary Lithoplasty System

FREMONT, Calif.–(BUSINESS WIRE)–Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced conformité européenne (CE) Mark for the company’s Coronary Lithoplasty® System for the treatment of calcified plaque in conjunction with stenting in patients with coronary artery disease. The Shockwave Medical Coronary Lithoplasty System is an innovative […]

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

LAKE FOREST, Calif.–(BUSINESS WIRE)–NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) was implanted through the jugular vein one week ago in a patient suffering from severe tricuspid regurgitation stemming from two failed tricuspid annuloplasty rings that were unable to maintain the patient’s […]

Abiomed (ABMD) Introduces 3rd Generation Impella CP® Heart Pumps At SCAI 2017

DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation Impella CP heart pump at the Annual meeting of the Society for Cardiovascular and Angiography Interventions (SCAI 2017) in New Orleans, LA. […]